Michael Parisi MBA

Michael joined Lumanity in late 2021 through the acquisition of Guidemark Health, where he was the CEO for 3 years. Michael has spent his entire career working across all aspects of product development and commercialization within the oncology and rare disease markets. Before joining Guidemark Health, Michael spent over 17 years at WPP, running the specialty marketing divisions of Ogilvy CommonHealth Worldwide.

Michael has always been passionate about identifying healthcare’s biggest challenges and working collaboratively to create innovative solutions that change the way diseases are diagnosed, viewed and treated. A brand strategist by day, he is a passionate patient advocate at heart, currently serving as the Board President for CancerCare (a US-based non-profit organization) and is a member of the Board of Directors for LUNGevity (a non-profit organization focused on lung cancer). He has been recognized by PM 360 as one of the Top 100 Most Influential Leaders in Healthcare and the inaugural class of MM&M Pinnacle Awards, designed to celebrate the marketers, strategists and creators who have scaled the industry’s heights — but aren’t ready to stop climbing anytime soon.

As an undergraduate, Michael studied Psychology at Montclair State University and earned an MBA with a concentration in Corporate Finance from Fairleigh Dickinson University.